BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6208666)

  • 1. Streptococcal defenses against host immune attack: the M protein-fibrinogen interaction.
    Whitnack E; Dale JB; Beachey EH
    Trans Assoc Am Physicians; 1983; 96():197-202. PubMed ID: 6208666
    [No Abstract]   [Full Text] [Related]  

  • 2. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
    Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
    J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes.
    Sandin C; Carlsson F; Lindahl G
    Mol Microbiol; 2006 Jan; 59(1):20-30. PubMed ID: 16359315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular structure and immunochemistry of streptococcal M-protein].
    Ookuni H
    Tanpakushitsu Kakusan Koso; 1990 Nov; 35(15):2839-51. PubMed ID: 1701908
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
    Courtney HS; Hasty DL; Dale JB
    Mol Microbiol; 2006 Feb; 59(3):936-47. PubMed ID: 16420362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tetravalent group A streptococcal M protein vaccine.
    Dale JB; Chiang EY; Lederer JW
    J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group A streptococcal M proteins: virulence factors and protective antigens.
    Robinson JH; Kehoe MA
    Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor.
    Johnsson E; Berggård K; Kotarsky H; Hellwage J; Zipfel PF; Sjöbring U; Lindahl G
    J Immunol; 1998 Nov; 161(9):4894-901. PubMed ID: 9794423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common protective antigens of group A streptococcal M proteins masked by fibrinogen.
    Whitnack E; Dale JB; Beachey EH
    J Exp Med; 1984 Apr; 159(4):1201-12. PubMed ID: 6368736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
    Jacks-Weis J; Kim Y; Cleary PP
    J Immunol; 1982 Apr; 128(4):1897-902. PubMed ID: 7037956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a polypeptide fragment of the streptococcal group A M protein conjugated with an acrylic acid N-vinylpyrrolidone copolymer.
    Lyampert IM; Semenova EN; Sanina VYu ; Puchkova NG; Nekrasov AV
    Biomed Sci; 1991; 2(4):410-4. PubMed ID: 1797145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M antigens of group A streptococci isolated by means of immunochromatography. Biochemical and serological properties.
    Kühnemund O; Havlicek J; Knöll H; Sjöquist J
    Immunobiology; 1981; 159(3):244-55. PubMed ID: 7021402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development.
    McArthur JD; Walker MJ
    Mol Microbiol; 2006 Jan; 59(1):1-4. PubMed ID: 16359313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group A streptococcal antigens and vaccine potential.
    Kehoe MA
    Vaccine; 1991 Nov; 9(11):797-806. PubMed ID: 1722063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms and manifestations of population variability in Streptococcus pyogenes].
    Kaminskiĭ GD; Beliakov VD
    Vestn Akad Med Nauk SSSR; 1986; (7):10-7. PubMed ID: 2428180
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice.
    Kawabata S; Kunitomo E; Terao Y; Nakagawa I; Kikuchi K; Totsuka K; Hamada S
    Infect Immun; 2001 Feb; 69(2):924-30. PubMed ID: 11159987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
    Dale JB; Washburn RG; Marques MB; Wessels MR
    Infect Immun; 1996 May; 64(5):1495-501. PubMed ID: 8613352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway.
    Carlsson F; Sandin C; Lindahl G
    Mol Microbiol; 2005 Apr; 56(1):28-39. PubMed ID: 15773976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitopes of streptococcal M proteins shared with cardiac myosin.
    Dale JB; Beachey EH
    J Exp Med; 1985 Aug; 162(2):583-91. PubMed ID: 2410530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of group A type 1 streptococcal M protein with fibrinogen.
    Kühnemund O; Havlicek J; Knöll H; Sjöquist J; Köhler W
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):201-9. PubMed ID: 3898717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.